Apigenin inhibits TGF-β1 induced fibroblast-to- myofibroblast transition in human lung fibroblast populations

Pharmacological Reports

Volumn 65, Issue 1, 2013, Pages 164-172

  Wójcik, Katarzyna A ^a,b   Skoda, Marta ^a   Koczurkiewicz, Paulina ^a,b   Sanak, Marek ^b   Czyz, Jarosław ^a   Michalik, Marta ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Apigenin; Asthma; Human bronchial fibroblasts; IMR 90 cells; Myofibroblasts; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APIGENIN; MESSENGER RNA; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CELL FRACTIONATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG FIBROBLAST; MYOFIBROBLAST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84875775046     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)70974-5     Document Type: Article

References (49)

1. Al-Muhsen S, Johnson JR, Hamid Q: Remodeling in asthma. J Allergy Clin Immunol, 2011, 128, 451-462.
2. Anandan C, Nurmatov U, van Schayck OC, Sheikh A: Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy, 2010, 65, 152-167.
3. Arts IC, Hollman PC: Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr, 2005, 81, 317-325.
4. Balasubramanian S, Zhu L, Eckert RL: Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cd Tyr311. J Biol Chem, 2006, 281, 36162-36172.
5. Barnes PJ: Corticosteroids: the drugs to beat. Eur J Pharmacol, 2006, 8, 2-14.
6. Bosnjak B, Stelzmueller B, Erb KJ, Epstein MM: Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res, 2011, 25, 102-114.
7. Brellier F, Tucker RP, Chiquet-Ehrismann R: Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports, 2009, 19, 511-519.
8. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q: Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol, 2003, 111, 1293-1298.
9. Chen CY, Peng WH, Wu LC, Wu CC, Hsu SL: Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis. J Agric Food Chem, 2010, 24, 11653-11661.
10. Clere N, Faure S, Martinez MC, Andriantsitohaina R: Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem, 2011, 1, 62-77.
11. Czyż J, Madeja Z, Irmer U, Korohoda W, Hülser DF: Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int J Cancer, 2005, 10, 12-18.
12. Descalzi D, Folli C, Scordamaglia F, Riccio AM, Gamalero C, Canonica GW: Importance of fibroblasts-myofibroblasts in asthma-induced airway remodeling. Recent Pat Inflamm Allergy Drug Discov, 2007, 1, 237-241.
13. Durrani SR, Viswanathan RK, Busse WW: What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol, 2011, 128, 439-448.
14. Franzen CA, Amargo E, Todoroviæ V, Desai BV, Huda S, Mirzoeva S, Chiu K et al.: The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res (Phila), 2009, 9, 830-841.
15. Gaffin JM, Phipatanakul W: The role of indoor allergens in the development of asthma. Curr Opin Allergy Clin Immunol, 2009, 9, 128-35.
16. Galanty A, Michalik M, Sȩdek L, Podolak I: The influence of LTS-4, a saponoside from Lysimachia thyrsiflora L., on human skin fibroblasts and human melanoma cells. Cell Mol Biol Lett, 2008, 13, 585-598.
17. González R, Ballester I, López-Posadas R, Suárez MD, Zarzuelo A, Martínez-Augustin O, Sánchez de Medina F: Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr, 2011, 51, 331-362.
18. Grewal JS, Mukhin YV, Garnovskaya MN, Raymond JR, Greene EL: Serotonin 5-HT2A receptor induces TGF-β1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol, 1999, 276, F922-930.
19. Guan H, Gao L, Zhu L, Yan L, Fu M, Chen C, Dong X et al.: Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation. J Cell Biochem, 2012, 113, 1198-1207.
20. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q: Role of transforming growth factor-b in airway remodeling in asthma. Am J Respir Cell Mol Biol, 2011, 44, 127-133.
21. Hardie WD, Glasser SW, Hagood JS: Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol, 2009, 175, 3-16.
22. Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S, Fujimoto M et al.: Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol, 2004, 134, 135-140.
23. Holgate ST: Alook at the pathogenesis of asthma: the need for a change in direction. DiscovMed, 2010, 9, 439-447.
24. Holgate ST: Genetic and environmental interaction in allergy and asthma. J Allergy Clin Immunol, 1999, 104, 1139-1146.
25. Hu XW, Meng D, Fang J: Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 2008, 29, 2369-2376.
26. Hwang YP, Oh KN, Yun HJ, Jeong HG: The flavonoids apigenin and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells. J Dermatol Sci, 2011, 61, 23-31.
27. Kang OH, Lee JH, Kwon DY: Apigenin inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells. Immunopharmacol Immunotoxicol, 2011, 33, 473-479.
28. Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, Ohkawara T et al.: Flavonoids and related compounds as anti-allergic substances. Allergol Int, 2007, 56, 113-123.
29. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD: Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med, 2002, 113, Suppl 9B, 71S-88S.
30. Kumazawa Y, Kawaguchi K, Takimoto H: Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr Pharm Des, 2006, 12, 4271-4279.
31. Lepley DM, Pelling JC, Lepley DM, Pelling JC: Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog, 1997, 19, 74-82.
32. Li RR, Pang LL, Du Q, Shi Y, Dai WJ, Yin KS: Apigenin inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma. Immunopharmacol Immunotoxicol, 2010, 32, 364-370.
33. Makinde T, Murphy RF, Agrawal DK: The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol, 2007, 85, 348-356.
34. Mauad T, Bel EH, Sterk PJ: Asthma therapy and airway remodeling. J Allergy Clin Immunol, 2007, 120, 997-1009.
35. McAnulty RJ: Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol, 2007, 39, 666-671.
36. Michalik M, Pierzchalska M, Legutko A, Ura M, Ostaszewska A, Soja J, Sanak M: Asthmatic bronchial fibroblasts demonstrate enhanced potential to differentiate into myofibroblasts in culture. Med Sci Monit, 2009, 15, 194-201.
37. Michalik M, Pierzchalska M, Włodarczyk A, Wójcik KA, Czyż J, Sanak M, Madeja Z: Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell-cell contacts. Respir Med, 2011, 105, 1467-1475.
38. MichalikM,Wójcik KA, Jakieła B, Szpak K, Pierzchalska M, Sanak M, Madeja Z, Czyż J: Lithium attenuates TGF-β1-induced fibroblasts to myofibroblasts transition in bronchial fibroblasts derived from asthmatic patients. J Allergy, 2012, 2012:206109, doi: 10.1155/2012/206109.
39. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP: ISAAC Phase Two Study Group: Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax, 2010, 65, 516-522.
40. Pauwels EK: The protective effect of the Mediterranean diet: focus on cancer and cardiovascular risk. Med Princ Pract, 2011, 20, 103-111.
41. Peters SP, Ferguson G, Deniz Y, Reisner C: Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med, 2006, 100, 1139-1151.
42. Ricupero DA, Poliks CF, Rishikof DC, Kuang PP, Goldstein RH: Apigenin decreases expression of the myofibroblast phenotype. FEBS Lett, 2001, 28, 15-21.
43. Shaheen SO, Sterne JA, Thompson RL, Songhurst CE, Margetts BM, Burney PG: Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med, 2001, 164, 1823-1828.
44. Shukla S, Gupta S: Apigenin: a promising molecule for cancer prevention. Pharm Res, 2010, 27, 962-978.
45. Shukla S, Gupta S: Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle, 2007, 2, 1102-1114.
46. Strzȩpa A, Szczepanik M: IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders. Pharmacol Rep, 2011, 63, 30-44.
47. Westergren-Thorsson G, Larsen K, Nihlberg K, Andersson-Sjöland A, Hallgren O, Marko-Varga G, Bjermer L: Pathological airway remodelling in inflammation. Clin Respir J, 2010, 4, 1-8.
48. Wilson MS, Wynn TA: Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol, 2009, 2, 103-121.
49. Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL: Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem, 2011, 11, 169-177.